Diffuse large B cell lymphoma biopsy: Difference between revisions
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
*FNA not used for Diagnosis. | *FNA not used for Diagnosis. | ||
*To view findings on biopsy characteristic of each morphological variant of diffuse large B cell lymphoma, click [[Diffuse large B cell lymphoma pathophysiology #Microscopic Pathology|'''here''']]. | *To view findings on biopsy characteristic of each morphological variant of diffuse large B cell lymphoma, click [[Diffuse large B cell lymphoma pathophysiology #Microscopic Pathology|'''here''']]. | ||
*Diagnosis of DLBCL on Biopsy should always be confirmed by Immunophenotypic techniques like Flow cytometry or IHC or Both. | *morphological Diagnosis of DLBCL on Biopsy should always be confirmed by Immunophenotypic techniques like Flow cytometry or IHC or Both. | ||
==References== | ==References== |
Revision as of 18:50, 11 June 2018
Diffuse large B cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diffuse large B cell lymphoma biopsy On the Web |
American Roentgen Ray Society Images of Diffuse large B cell lymphoma biopsy |
Directions to Hospitals Treating Diffuse large B cell lymphoma |
Risk calculators and risk factors for Diffuse large B cell lymphoma biopsy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Excisional Lymph node or extranodal tissue biopsy is diagnostic of diffuse large B cell lymphoma.
Biopsy
- Surgical Excision Biopsy of Lymph node or extranodal tissue is diagnostic of diffuse large B cell lymphoma.[1]
- Needle-Core Excision and Endoscopic Biopsies should be reserved for patients in which surgery is too risky or impractical.
- FNA not used for Diagnosis.
- To view findings on biopsy characteristic of each morphological variant of diffuse large B cell lymphoma, click here.
- morphological Diagnosis of DLBCL on Biopsy should always be confirmed by Immunophenotypic techniques like Flow cytometry or IHC or Both.
References
- ↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov